早期毒性試験の世界市場レポート 2025年

早期毒性試験の市場規模は、今後数年間で力強い成長が見込まれます。2029年には22億2,000万米ドルに成長し、CAGRは8.5%に達する見込みです。予測期間中に予測される成長は、医薬品の安全性に対する規制圧力の高まり、医薬品副作用の発生率の上昇、美意識の高まり、早期毒性試験の増加、毒性問題に対する意識の高まりなどの要因によるものと考えられます。この期間に予想される主な動向には、インシリコ毒性予測モデルの利用、オルガンオンチップ技術の進歩、ハイスループットスクリーニング（HTS）、分子毒性学の発展、毒性試験における幹細胞の利用などがあります。

個別化医療が重視されるようになったことが、早期毒性試験市場の成長を促進すると予想されます。個別化医療は、患者固有の遺伝的、環境的、ライフスタイル的要因に基づいて、治療やヘルスケア戦略を個々の患者に合わせるものです。このアプローチは、各人の遺伝的体質に合わせて治療をカスタマイズすることができるため、有効性を高め、適切な薬剤を適切な用量で投与することで副作用を減らすことができ、支持を集めています。個別化医療は、遺伝子、バイオマーカー、患者固有のデータを用いて、個人が薬剤にどのように反応するかを予測し、副作用を減らし、安全性評価を改善することで、早期毒性試験をサポートします。例えば、2024年2月に発表された個別化医療連合（Personalized Medicine Coalition）の報告書によると、2023年に米国FDAが承認した希少疾患の個別化治療薬は16種類であり、2022年の6種類から増加しています。これらの新規承認には、7つのがん治療薬と3つのその他の疾患の治療が含まれていました。したがって、個別化医療の増加は早期毒性試験市場の成長を後押ししています。

早期毒性試験市場の企業は、ZBEScreenのような技術的進歩に注力しています。ZBEScreenは、物質の潜在的な有害作用を検出するためのハイスループット早期毒性試験にゼブラフィッシュ胚を利用しています。例えば、ガーナを拠点とする受託研究機関AsedaSciencesは、2025年3月、ゼブラフィッシュの毒性学と発達衛生を専門とする米国の研究所Tanguay Labと共同で、先進的なゼブラフィッシュスクリーニングサービスを導入しました。このサービスは、最先端のハイスループット技術を駆使して毒性をリアルタイムで評価するもので、発育や行動の変化をモニタリングしながら、医薬品や化学物質の安全性を正確、効率的、かつ倫理的に試験することができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の早期毒性試験市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の早期毒性試験市場：成長率分析
• 世界の早期毒性試験市場の実績：規模と成長、2019～2024年
• 世界の早期毒性試験市場の予測：規模と成長、2024～2029年、2034年
• 世界の早期毒性試験総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の早期毒性試験市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• インビボ
• インビトロ
• インシリコ
• 世界の早期毒性試験市場：毒性タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 細胞毒性
• 遺伝毒性
• 発がん性
• 生殖毒性
• 生態毒性
• 世界の早期毒性試験市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• マイクロ流体技術
• バイオインフォマティクス
• ハイコンテントスクリーニング
• 3D細胞培養
• 世界の早期毒性試験市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 医薬品開発
• 環境モニタリング
• がん研究
• 材料試験
• 規制コンプライアンス
• 世界の早期毒性試験市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 製薬
• 食品
• 化学
• 化粧品
• その他
• 世界の早期毒性試験市場：インビボのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 急性毒性試験
• 慢性毒性試験
• 発がん性試験
• 発達・生殖毒性（DART）試験
• 神経毒性試験
• 世界の早期毒性試験市場：インビトロのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 細胞ベースアッセイ
• 生化学アッセイ
• ハイスループットスクリーニング（HTS）
• 3D細胞培養システム
• オルガンチップモデル
• 世界の早期毒性試験市場：インシリコタイプのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 計算毒性学
• 予測モデリング
• 定量的構造活性相関（QSAR）モデル
• 機械学習による毒性予測
• 生理学的薬物動態（PBPK）モデリング

第7章 地域別・国別分析

• 世界の早期毒性試験市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の早期毒性試験市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 早期毒性試験市場：競合情勢
• 早期毒性試験市場：企業プロファイル
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • BD bioscience Overview, Products and Services, Strategy and Financial Analysis
  • ICON plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• SGS S.A.
• Agilent Technologies
• Eurofins Scientific
• WuXi AppTec.
• Charles River Laboratories
• Charles River Laboratories Edinburgh Ltd.
• Sigma Aldrich
• Bio-rad
• Bruker Corporation
• Medpace Inc.
• Evotec AG
• PerkinElmer Inc.
• QPS LLC
• Ocimum Biosolutions
• Enzo Biochem Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 早期毒性試験市場2029：新たな機会を提供する国
• 早期毒性試験市場2029：新たな機会を提供するセグメント
• 早期毒性試験市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Early toxicity testing refers to the initial assessment of a substance's potential harmful effects before it advances to later stages of development, such as clinical trials or commercial use. This testing is primarily conducted in drug development, chemical safety evaluation, and environmental health studies.

The main types of early toxicity testing include in-vivo, in-vitro, and in-silico. In-vivo testing involves experiments conducted within a living organism, such as animals or humans, to observe biological effects in a natural setting. The various types of toxicity include cytotoxicity, genotoxicity, carcinogenicity, reproductive toxicity, and ecotoxicity, with technologies such as microfluidics, bioinformatics, high-content screening, and 3D cell cultures being used in these evaluations. These tests have diverse applications in drug development, environmental monitoring, cancer research, material testing, and regulatory compliance, and are employed by industries such as pharmaceuticals, food, chemicals, cosmetics, and others.

The early toxicity testing market research report is one of a series of new reports from The Business Research Company that provides early toxicity testing market statistics, including early toxicity testing industry global market size, regional shares, competitors with an early toxicity testing market share, detailed early toxicity testing market segments, market trends and opportunities, and any further data you may need to thrive in the early toxicity testing industry. This early toxicity testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The early toxicity testing market size has grown strongly in recent years. It will grow from $1.47 billion in 2024 to $1.60 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth during the historic period can be attributed to factors such as the rise in ethical concerns, increased awareness of human and environmental health, growing public health crises and environmental disasters, a heightened focus on endocrine disruptors, and the growing need for harmonized standards.

The early toxicity testing market size is expected to see strong growth in the next few years. It will grow to $2.22 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The projected growth during the forecast period can be attributed to factors such as increasing regulatory pressure for drug safety, a rising incidence of adverse drug reactions, greater aesthetic consciousness, an increase in early toxicity testing, and heightened awareness of toxicity issues. Key trends expected in this period include the use of in-silico toxicity prediction models, advancements in organ-on-a-chip technology, high-throughput screening (HTS), developments in molecular toxicology, and the use of stem cells in toxicity testing.

The growing emphasis on personalized medicine is expected to drive the growth of the early toxicity testing market. Personalized medicine tailors treatments and healthcare strategies to individual patients based on their unique genetic, environmental, and lifestyle factors. This approach is gaining traction because it allows treatments to be customized to each person's genetic makeup, which can enhance effectiveness and reduce side effects by ensuring the right drug is given at the right dose. Personalized medicine supports early toxicity testing by using genetic, biomarker, and patient-specific data to predict how individuals will respond to drugs, reducing adverse effects and improving safety assessments. For example, a report from the Personalized Medicine Coalition in February 2024 noted that in 2023, the U.S. FDA approved 16 new personalized treatments for rare diseases, an increase from six in 2022. These new approvals included seven cancer drugs and three treatments for other conditions. Therefore, the rise in personalized medicine is helping drive the growth of the early toxicity testing market.

Companies in the early toxicity testing market are focusing on technological advancements such as ZBEScreen. ZBEScreen utilizes zebrafish embryos for high-throughput early toxicity testing to detect potential harmful effects of substances. For instance, in March 2025, AsedaSciences, a Ghana-based contract research organization, introduced an advanced zebrafish screening service in collaboration with the Tanguay Lab, a U.S.-based research lab specializing in zebrafish toxicology and developmental health. This service uses cutting-edge high-throughput technologies to assess toxicity in real time, offering precise, efficient, and ethical testing of drug and chemical safety while monitoring developmental and behavioral changes.

In September 2024, Scantox Group, a Denmark-based preclinical contract research organization, acquired Gentronix for an undisclosed amount. This acquisition will help Scantox expand its early toxicity testing capabilities by incorporating Gentronix's expertise in genetic toxicology and predictive safety assessment, which will enhance its services for the pharmaceutical and chemical industries. Gentronix, a UK-based organization, specializes in genetic toxicology testing, with a focus on mutagenicity and genotoxicity.

Major players in the early toxicity testing market are Merck KGaA, Thermo Fisher Scientific, Danaher Corporation, BD bioscience, ICON plc, SGS S.A., Agilent Technologies, Eurofins Scientific, WuXi AppTec., Charles River Laboratories, Charles River Laboratories Edinburgh Ltd., Sigma Aldrich, Bio-rad, Bruker Corporation, Medpace Inc., Evotec AG, PerkinElmer Inc., QPS LLC, Ocimum Biosolutions, Enzo Biochem Inc.

North America was the largest region in the early toxicity testing market in 2024. Aisa-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in early toxicity testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the early toxicity testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The early toxicity testing market entities by providing services such as hepatotoxicity testing, neurotoxicity testing, and cardiotoxicity testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Early Toxicity Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on early toxicity testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for early toxicity testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The early toxicity testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: In-Vivo; In-Vitro; In-Silico
• 2) By Toxicity Type: Cytotoxicity; Genotoxicity; Carcinogenicity; Reproductive Toxicity; Ecotoxicity
• 3) By Technology: Microfluidics Technology; Bioinformatics; High-Content Screening; 3D Cell Cultures
• 4) By Application: Drug Development; Environmental Monitoring; Cancer Research; Material Testing; Regulatory Compliance
• 5) By End User: Pharmaceuticals Industry; Food Industry; Chemicals Industry; Cosmetics Industry; Other End-Users
• Sub Segments:
• 1) By In-Vivo Type: Acute Toxicity Testing; Chronic Toxicity Testing; Carcinogenicity Testing; Developmental & Reproductive Toxicity (DART) Testing; Neurotoxicity Testing
• 2) By In-Vitro Type: Cell-Based Assays; Biochemical Assays; High-Throughput Screening (HTS); 3D Cell Culture Systems; Organ-on-a-Chip Models
• 3) By In-Silico Type: Computational Toxicology; Predictive Modeling; Quantitative Structure-Activity Relationship (QSAR) Models; Machine Learning-Based Toxicity Prediction; Physiologically Based Pharmacokinetic (PBPK) Modeling
• Companies Mentioned: Merck KGaA; Thermo Fisher Scientific; Danaher Corporation; BD bioscience; ICON plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Early Toxicity Testing Market Characteristics

3. Early Toxicity Testing Market Trends And Strategies

4. Early Toxicity Testing Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Early Toxicity Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Early Toxicity Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Early Toxicity Testing Market Growth Rate Analysis
• 5.4. Global Early Toxicity Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Early Toxicity Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Early Toxicity Testing Total Addressable Market (TAM)

6. Early Toxicity Testing Market Segmentation

• 6.1. Global Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In-Vivo
• In-Vitro
• In-Silico
• 6.2. Global Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cytotoxicity
• Genotoxicity
• Carcinogenicity
• Reproductive Toxicity
• Ecotoxicity
• 6.3. Global Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microfluidics Technology
• Bioinformatics
• High-Content Screening
• 3D Cell Cultures
• 6.4. Global Early Toxicity Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Development
• Environmental Monitoring
• Cancer Research
• Material Testing
• Regulatory Compliance
• 6.5. Global Early Toxicity Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceuticals Industry
• Food Industry
• Chemicals Industry
• Cosmetics Industry
• Other End-Users
• 6.6. Global Early Toxicity Testing Market, Sub-Segmentation Of In-Vivo Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Toxicity Testing
• Chronic Toxicity Testing
• Carcinogenicity Testing
• Developmental & Reproductive Toxicity (DART) Testing
• Neurotoxicity Testing
• 6.7. Global Early Toxicity Testing Market, Sub-Segmentation Of In-Vitro Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell-Based Assays
• Biochemical Assays
• High-Throughput Screening (HTS)
• 3D Cell Culture Systems
• Organ-on-a-Chip Models
• 6.8. Global Early Toxicity Testing Market, Sub-Segmentation Of In-Silico Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Computational Toxicology
• Predictive Modeling
• Quantitative Structure-Activity Relationship (QSAR) Models
• Machine Learning-Based Toxicity Prediction
• Physiologically Based Pharmacokinetic (PBPK) Modeling

7. Early Toxicity Testing Market Regional And Country Analysis

• 7.1. Global Early Toxicity Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Early Toxicity Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Early Toxicity Testing Market

• 8.1. Asia-Pacific Early Toxicity Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Early Toxicity Testing Market

• 9.1. China Early Toxicity Testing Market Overview
• 9.2. China Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Early Toxicity Testing Market

• 10.1. India Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Early Toxicity Testing Market

• 11.1. Japan Early Toxicity Testing Market Overview
• 11.2. Japan Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Early Toxicity Testing Market

• 12.1. Australia Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Early Toxicity Testing Market

• 13.1. Indonesia Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Early Toxicity Testing Market

• 14.1. South Korea Early Toxicity Testing Market Overview
• 14.2. South Korea Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Early Toxicity Testing Market

• 15.1. Western Europe Early Toxicity Testing Market Overview
• 15.2. Western Europe Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Early Toxicity Testing Market

• 16.1. UK Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Early Toxicity Testing Market

• 17.1. Germany Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Early Toxicity Testing Market

• 18.1. France Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Early Toxicity Testing Market

• 19.1. Italy Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Early Toxicity Testing Market

• 20.1. Spain Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Early Toxicity Testing Market

• 21.1. Eastern Europe Early Toxicity Testing Market Overview
• 21.2. Eastern Europe Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Early Toxicity Testing Market

• 22.1. Russia Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Early Toxicity Testing Market

• 23.1. North America Early Toxicity Testing Market Overview
• 23.2. North America Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Early Toxicity Testing Market

• 24.1. USA Early Toxicity Testing Market Overview
• 24.2. USA Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Early Toxicity Testing Market

• 25.1. Canada Early Toxicity Testing Market Overview
• 25.2. Canada Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Early Toxicity Testing Market

• 26.1. South America Early Toxicity Testing Market Overview
• 26.2. South America Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Early Toxicity Testing Market

• 27.1. Brazil Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Early Toxicity Testing Market

• 28.1. Middle East Early Toxicity Testing Market Overview
• 28.2. Middle East Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Early Toxicity Testing Market

• 29.1. Africa Early Toxicity Testing Market Overview
• 29.2. Africa Early Toxicity Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Early Toxicity Testing Market, Segmentation By Toxicity Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Early Toxicity Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Early Toxicity Testing Market Competitive Landscape And Company Profiles

• 30.1. Early Toxicity Testing Market Competitive Landscape
• 30.2. Early Toxicity Testing Market Company Profiles
  • 30.2.1. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. BD bioscience Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. ICON plc Overview, Products and Services, Strategy and Financial Analysis

31. Early Toxicity Testing Market Other Major And Innovative Companies

• 31.1. SGS S.A.
• 31.2. Agilent Technologies
• 31.3. Eurofins Scientific
• 31.4. WuXi AppTec.
• 31.5. Charles River Laboratories
• 31.6. Charles River Laboratories Edinburgh Ltd.
• 31.7. Sigma Aldrich
• 31.8. Bio-rad
• 31.9. Bruker Corporation
• 31.10. Medpace Inc.
• 31.11. Evotec AG
• 31.12. PerkinElmer Inc.
• 31.13. QPS LLC
• 31.14. Ocimum Biosolutions
• 31.15. Enzo Biochem Inc.

32. Global Early Toxicity Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Early Toxicity Testing Market

34. Recent Developments In The Early Toxicity Testing Market

35. Early Toxicity Testing Market High Potential Countries, Segments and Strategies

• 35.1 Early Toxicity Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Early Toxicity Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Early Toxicity Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer